🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 18 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/04/2009 | 5,20 | 6,00 | 4,60 | 4,90 | -10,91% | 26,92% | 16.210 |
| 23/04/2009 | 5,80 | 5,80 | 5,40 | 5,50 | +0,00% | 6,90% | 8.340 |
| 22/04/2009 | 5,30 | 7,00 | 5,30 | 5,50 | -1,79% | 32,08% | 9.280 |
| 21/04/2009 | 5,25 | 5,90 | 5,00 | 5,60 | +11,55% | 17,14% | 8.780 |
| 20/04/2009 | 5,72 | 5,80 | 5,00 | 5,02 | -11,93% | 13,99% | 11.120 |
| 17/04/2009 | 6,00 | 6,10 | 5,70 | 5,70 | -1,72% | 6,67% | 6.180 |
| 16/04/2009 | 5,80 | 6,20 | 5,66 | 5,80 | -1,69% | 9,31% | 7.800 |
| 15/04/2009 | 6,00 | 6,50 | 5,90 | 5,90 | -3,28% | 10,00% | 6.900 |
| 14/04/2009 | 6,00 | 6,50 | 5,50 | 6,10 | +10,91% | 16,67% | 10.190 |
| 13/04/2009 | 5,90 | 6,00 | 5,40 | 5,50 | -8,33% | 10,17% | 9.890 |
| 09/04/2009 | 6,10 | 7,00 | 5,90 | 6,00 | -3,23% | 18,03% | 8.350 |
| 08/04/2009 | 6,00 | 6,20 | 6,00 | 6,20 | +3,33% | 3,33% | 2.060 |
| 07/04/2009 | 6,02 | 6,40 | 6,00 | 6,00 | -1,64% | 6,64% | 5.350 |
| 06/04/2009 | 6,20 | 6,20 | 6,00 | 6,10 | -1,61% | 3,23% | 3.960 |
| 03/04/2009 | 7,00 | 7,20 | 6,20 | 6,20 | -11,68% | 14,29% | 9.760 |
| 02/04/2009 | 7,50 | 7,50 | 6,78 | 7,02 | +11,43% | 9,60% | 21.470 |
| 01/04/2009 | 5,80 | 6,70 | 5,78 | 6,30 | +12,50% | 15,86% | 19.140 |
| 31/03/2009 | 5,00 | 5,90 | 5,00 | 5,60 | +12,00% | 18,00% | 11.140 |
| 30/03/2009 | 5,40 | 5,42 | 4,90 | 5,00 | -7,41% | 9,63% | 5.770 |
| 27/03/2009 | 4,90 | 5,80 | 4,90 | 5,40 | +10,20% | 18,37% | 14.900 |
| 26/03/2009 | 4,60 | 5,00 | 4,60 | 4,90 | +6,52% | 8,70% | 9.450 |
| 25/03/2009 | 4,75 | 5,00 | 4,60 | 4,60 | -3,16% | 8,42% | 8.630 |
| 24/03/2009 | 4,80 | 4,80 | 4,50 | 4,75 | +3,26% | 6,25% | 10.440 |
| 23/03/2009 | 4,80 | 5,20 | 4,60 | 4,60 | -4,17% | 12,50% | 9.020 |
| 20/03/2009 | 4,90 | 4,90 | 4,70 | 4,80 | -2,04% | 4,08% | 3.320 |
| 19/03/2009 | 5,00 | 5,00 | 4,70 | 4,90 | +8,89% | 6,00% | 7.910 |
| 18/03/2009 | 4,50 | 4,80 | 4,50 | 4,50 | +2,27% | 6,67% | 7.460 |
| 17/03/2009 | 4,78 | 4,80 | 4,40 | 4,40 | -4,35% | 8,37% | 6.220 |
| 16/03/2009 | 4,80 | 4,80 | 4,42 | 4,60 | +12,20% | 7,92% | 8.080 |
| 13/03/2009 | 5,10 | 5,10 | 4,10 | 4,10 | -16,33% | 19,61% | 7.340 |